Franz Obermayr
Directeur Général chez Panoptes Pharma GmbH
Postes actifs de Franz Obermayr
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Directeur Général | 01/07/2013 | - |
| Fondateur | 01/07/2013 | - |
Historique de carrière de Franz Obermayr
Anciens postes connus de Franz Obermayr
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Directeur Général | 01/02/2021 | 26/07/2021 |
| Directeur Technique/Scientifique/R&D | 18/12/2020 | 31/12/2021 | |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01/01/2009 | 01/01/2013 |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Etats-Unis | 3 |
| Autriche | 2 |
| Irlande | 2 |
Opérationnelle
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
| Founder | 1 |
Sectorielle
| Health Technology | 4 |
| Retail Trade | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
- Bourse
- Insiders
- Franz Obermayr
- Expérience
